Abstract NC0604, a new analogue of bleomycin, was isolated from fermentation broth of Streptomyces verticillus var. pingyangensis n.var. The structure of NC0604 was elucidated by spectroscopic analyses. NC0604 had the same kernel structure as bleomycin, but a different terminal amine moiety determined as amidepropyl spermidine. NC0604 exhibited antibacterial activity against a wide range of bacterial species and showed cytotoxicity in vitro against human HepG 2 , KB, MCF-7, HCT116, BGC-823 and MCF-7/DOX cells with IC 50 values of 1.18, 1.21, 1.41, 1.83, 2.02, 1.45 mM, respectively. The antitumor activity of NC0604 against these cells was 3ϳ9 times higher than that of bleomycin; and the pulmonary toxicity of NC0604 was much lower than that of bleomycin.
activities and pulmonary toxicity are also presented and compared with those of bleomycin.
A stock culture of the strain Streptomyces verticillus var. pingyangensis n.var. was grown and maintained on an agar slant consisting of glucose 1.0%, soluble starch 1.0%, peptone 0.5%, agar 2.0%, and NaCl 0.5% (pH 7.2ϳ7.5) at 28°C. The stock culture was transferred into 250-ml Erlenmeyer flasks containing 50 ml of the seed medium consisting of soluble starch 2.5%, glucose 0.5%, soybean meal 3.5%, KH 2 PO 4 0.1%, ZnSO 4 0.05%, and CuSO 4 0.01% (pH 6.0ϳ6.5). The culture was incubated on a rotary shaker (agitated at 220 rpm) at 28°C for 48 hours. Ten milliliters of the seed culture was transferred to 500-ml Erlenmeyer flasks containing 100 ml of the producing medium with the same components as the seed medium. The fermentation was carried out at 29°C for 7ϳ8 days on a rotary shaker at 220 rpm. Antibiotic activity in the fermentation broth was determined by paper-disk agar diffusion assay using Bacillus subtilis.
The fermentation broth (25 liters) was adjusted to pH 2ϳ3 with oxalic acid solution and filtered. The fraction containing copper-chelated NC0604 was desalted with a column of x-5, and the column then eluted with 10% Me 2 CO soln (containing 0.01 M HCl). The active eluate was concentrated in vacuo and lyophilized to afford a blue powder of copper-chelated NC0604 (313 mg). Finally, copper-free NC0604 was prepared by treatments with dithizone (120 mg) in MeOH (10 ml). The solution was filtered, and the filtrate was precipitated with 4 times volume of Me 2 CO. After washed with acetone for three times and filtered, the precipitate was dissolved in distilled water, concentrated in vacuo and lyophilized to give pure copper-free compound NC0604 (266 mg).
The physico-chemical properties of NC0604 are summarized in Table 1 .
The copper-chelated NC0604 showed UV absorption maximum at 243ϳ245 nm and at 292ϳ295 nm, respectively, and the intensity ratio of the two absorption maximum is 1.23. As for copper-free preparation, absorption at 243ϳ245 nm turned into a shoulder peak.
NC0604 showed a typical UV spectrum similar to that of bleomycin.
The IR spectrum indicated the presence of OH/NH groups (3385 cm Ϫ1 ), CϭO group (1718 cm Ϫ1 ), CONH (1653 and 1553 cm Ϫ1 ) and OH group (1050 cm Ϫ1 ). These absorptions suggested that there was a glycopeptide structure in the molecule of the antibiotic. The shift data of 1 H-NMR spectrum of copper-free NC0604 at d H 7ϳ9 ppm indicated four aromatic protons, which belonged to the thiazole ring and imidazole ring of the kernel structure of bleomycin molecule. They are valuable characteristics for identification of bleomycins.
We assigned the 13 C signals of NC0604 by comparison with 13 C-NMR data of bleomycins reported previously [2, 3] and by analysis of 1 H-13 C COSY, heteronuclear single quantum correlation (HSQC) and heteronuclear multiple bond correlation (HMBC) spectra of NC0604. The 13 C-NMR spectral data are tabulated in Table 2 in comparison with those of bleomycin A 2 presented in the previous paper [3] . The numbering of the parts in the NC0604 molecule 748 follows the convention used in the previous paper [3] as shown in Fig. 1 . The signals of the carbons constituting the kernel structure of NC0604 are consistent with those of bleomycin A 2 . Therefore, we inferred that these two compounds are different from each other only in terminal amine moiety (R). Except for the signals of the carbons that constitute the NC0604 skeleton, the remains were all assigned to the terminal amine moiety. In the HMBC spectrum, the signal at d C 39.1 (R-a) showed a cross peak with a proton at d 
respectively. Moreover, the methylene of R-a (d H 3.58) showed a cross peak with a signal at d C 166.3 (VI-CO) and the methylene signal at d H 2.79 (R-i-CH 2 ) showed a cross peak with the carbonyl signal at d C 177.5 (R-CO). Therefore, the assignments for carbons of R moiety were determined as shown in Table 2 and the 13 C-connectivities revealed by analysis of the HMBC spectrum are indicated with a bold line in Fig. 1 .
NC0604 exhibited antibacterial activity against members of a wide range of bacterial species. The antibacterial activity of NC0604 is shown in Table 3 . Better antibacterial activities were observed against members of Bacillus species and some Gram-negative bacteria. Table 4 shows the growth-inhibitory activity in vitro of NC0604 toward human tumour cells. In comparison with that of bleomycin, NC0604 had a 3 to 9 times higher activity against tumour cells such as HepG2, KB, MCF-7, HCT116, BGC-823 and MCF-7/DOX.
The pulmonary toxicity for mice was determined in male Kunming mice. 10 mg/kg of the test compounds were injected intraperitoneally daily for 10 days. The pulmonary toxicity was evaluated by determining the content of hydroxyproline (HYP) and observing the histopathological changes of the lung tissues at day 28 after administration of NC0604 and bleomycin, respectively. The content of HYP in the lung tissues treated with NC0604 was 1.4 times lower than that treated with bleomycin (pϽ0.01). According to Ashcroft's [4] method, the degree of pulmonary fibrosis by NC0604 was measured microscopically as grade 2ϳ3, showing moderate thickening of walls without obvious damage to lung architecture, while bleomycin was measured as grade 6ϳ7, meaning severe distortion of structure and large fibrous areas. Obviously, NC0604 had reduced pulmonary toxicity. 
